SCHEMBL15038342

SCHEMBL15038342

Cc1c(N)nnc(-c2ccncc2)c1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 2/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 2/20 0.37
MEN1 O00255 1/20 0.37
CYP2D6 P10635 1/20 0.37
CHRM1 P11229 1/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 1/20 0.37
KCNA1 Q09470 1/20 0.37
MAPK14 Q16539 4/20 0.37
MAPK11 Q15759 2/20 0.37
CSNK1D P48730 1/20 0.37
SMO Q99835 1/20 0.36
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15038351 0.83 CLK4 (0.52) LMNAMAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL15038352 0.80 ADORA2A (0.49) LMNAMAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL26242537 0.78 MAPT (0.43) LMNAMAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL15038353 0.77 KMT2A (0.45) MAPTSMN1; SMN2ALDH1A1KDM4EHSD17B10
SCHEMBL15038312 0.77 NPC1 (0.45) SMN1; SMN2ALDH1A1KDM4EHPGDMAPK14
SCHEMBL15038380 0.73 ALDH1A1 (0.47) MAPTSMN1; SMN2ALDH1A1HSD17B10HPGD
SCHEMBL28323441 0.72 KDM4E (0.38) SMN1; SMN2KDM4EHPGDMAPK14MAPK11
SCHEMBL9775493 0.72 KDM4E (0.58) LMNAMAPTSMN1; SMN2ALDH1A1KDM4E
SCHEMBL27976843 0.72 ADORA2A (0.47) LMNAMAPTKDM4EHSD17B10MAPK1
SCHEMBL15038415 0.71 ADORA2A (0.53) ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318389-B1 PYRIDAZINE DERIVATIVES AS SMO INHIBITORS NOVARTIS AG (CH) 2013-06-19 EP disclosed